We are live on !
Find out more
Emerald Acquisition Portfolio holdings
AUM
$51.8B
Turnover
12.96%
This Fund
S&P 500
This Quarter Est. Return
+5.73%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$51.8B
AUM Growth
-$5.97B
(-10%)
Cap. Flow
-$8.46B
Cap. Flow % of AUM
Cap. Flow %
-16.35%
Top 10 Holdings %
Top 10 Hldgs %
10.38%
Holding
3,194
New
200
Increased
788
Reduced
1,868
Closed
214
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KeyCorp
KEY
|
+$59.1M |
| 2 |
IHS Markit Ltd. Common Shares
INFO
|
+$56.2M |
| 3 |
Du Pont De Nemours E I
DD
|
+$54M |
| 4 |
Alibaba
BABA
|
+$47.2M |
| 5 |
McKesson
MCK
|
+$43.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC CORPORATION
EMC
|
+$142M |
| 2 |
Johnson & Johnson
JNJ
|
+$133M |
| 3 |
Wells Fargo
WFC
|
+$131M |
| 4 |
TSMC
TSM
|
+$120M |
| 5 |
Corning
GLW
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.36% |
| 2 | Healthcare | 13.13% |
| 3 | Technology | 12.22% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Amgen
AMGN
$237B
| $172M | 0.33% |
1,030,764
-247,993
| -19% | -$41.9M |
2016 Q2
1 quarter
|
|
52
Scotiabank
BNS
$112B
| $169M | 0.33% |
3,190,631
+142,132
| +5% | +$7.35M |
2016 Q2
1 quarter
|
|
53
Chubb
CB
$138B
| $168M | 0.32% |
1,335,223
-89,912
| -6% | -$11.4M |
2016 Q2
1 quarter
|
|
54
RTX Corp
RTX
$261B
| $165M | 0.32% |
2,584,815
-178,017
| -6% | -$11.8M |
2016 Q2
1 quarter
|
|
55
Chevron
CVX
$443B
| $164M | 0.32% |
1,593,033
-577,121
| -27% | -$58.9M |
2016 Q2
1 quarter
|
|
56
Thermo Fisher Scientific
TMO
$254B
| $163M | 0.32% |
1,028,124
-330,480
| -24% | -$50.9M |
2016 Q2
1 quarter
|
|
57
Mondelez International
MDLZ
$81.7B
| $159M | 0.31% |
3,629,699
-632,958
| -15% | -$27.8M |
2016 Q2
1 quarter
|
|
58
Accenture
ACN
$146B
| $158M | 0.31% |
1,297,446
-251,685
| -16% | -$28.7M |
2016 Q2
1 quarter
|
|
59
Elevance Health
ELV
$95.5B
| $158M | 0.31% |
1,263,784
-586,776
| -32% | -$75.8M |
2016 Q2
1 quarter
|
|
60
3M
MMM
$88.4B
| $156M | 0.3% |
1,060,645
-164,378
| -13% | -$24.5M |
2016 Q2
1 quarter
|
|
61
Occidental Petroleum
OXY
$62.9B
| $155M | 0.3% |
2,128,462
+171,978
| +9% | +$12.9M |
2016 Q2
1 quarter
|
|
62
Bristol-Myers Squibb
BMY
$126B
| $155M | 0.3% |
2,878,054
+146,987
| +5% | +$9.44M |
2016 Q2
1 quarter
|
|
63
HDFC Bank
HDB
$119B
| $155M | 0.3% |
8,619,692
-681,460
| -7% | -$12M |
2016 Q2
1 quarter
|
|
64
Booking.com
BKNG
$123B
| $155M | 0.3% |
2,628,250
-236,000
| -8% | -$13.2M |
2016 Q2
1 quarter
|
|
65
GE Aerospace
GE
$311B
| $154M | 0.3% |
1,086,456
-358,907
| -25% | -$53.5M |
2016 Q2
1 quarter
|
|
66
BP
BP
$127B
| $147M | 0.28% |
4,977,042
-282,901
| -5% | -$8.21M |
2016 Q2
1 quarter
|
|
67
Mettler-Toledo International
MTD
$32.7B
| $145M | 0.28% |
344,426
-48,183
| -12% | -$19.1M |
2016 Q2
1 quarter
|
|
68
Altria Group
MO
$125B
| $144M | 0.28% |
2,274,096
-1,107,779
| -33% | -$73.6M |
2016 Q2
1 quarter
|
|
69
Moody's
MCO
$82.3B
| $143M | 0.28% |
1,324,004
-263,782
| -17% | -$27.7M |
2016 Q2
1 quarter
|
|
70
US Bancorp
USB
$92.1B
| $143M | 0.28% |
3,328,381
-503,953
| -13% | -$21.4M |
2016 Q2
1 quarter
|
|
71
Qualcomm
QCOM
$188B
| $139M | 0.27% |
2,028,588
-523,153
| -21% | -$31.8M |
2016 Q2
1 quarter
|
|
72
Johnson Controls International
JCI
$89.6B
| $138M | 0.27% |
2,967,360
+313,004
| +12% | +$14.5M |
2016 Q2
1 quarter
|
|
73
PG&E
PCG
$39.6B
| $138M | 0.27% |
2,255,620
+464,784
| +26% | +$29.5M |
2016 Q2
1 quarter
|
|
74
Baidu
BIDU
$27.4B
| $136M | 0.26% |
749,100
-157,020
| -17% | -$27.2M |
2016 Q2
1 quarter
|
|
75
UBS Group
UBS
$145B
| $134M | 0.26% |
9,821,194
-2,830,772
| -22% | -$38.5M |
2016 Q2
1 quarter
|
|
Similar funds
ACN
Emerald Acquisition's Q3 2016 Portfolio in Review
As of Q3 2016, Emerald Acquisition held 3,194 positions worth $51.8B, down 10% from $57.7B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Emerald Acquisition withdrew a net $8.46B in Q3 2016, closing 214 positions and reducing 1,868 holdings. Its most notable exit was EMC CORPORATION, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Emerald Acquisition opened a new position in Novo Nordisk worth $13.9M.
- Emerald Acquisition's largest Q3 2016 buy was Novo Nordisk: 666,610 shares worth $13.9M.
- Emerald Acquisition added most to KeyCorp in Q3 2016, an estimated $59.1M increase.
- Emerald Acquisition's biggest Q3 2016 reduction was Johnson & Johnson, cutting an estimated $133M.
- Emerald Acquisition fully exited EMC CORPORATION in Q3 2016, selling an estimated $142M.
- Emerald Acquisition's ten largest holdings make up 10% of its $51.8B portfolio in Q3 2016.
- Emerald Acquisition opened 200 new positions and closed 214 in Q3 2016.
- Emerald Acquisition's portfolio value fell 10% quarter-over-quarter to $51.8B.
Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.